Find and Pitch Jounalists, Get Your Story Covered

Tags: dreams sleep REMS Training Documentation

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	NICE endorses Neuraxpharm’s ublituximab for treating MS - 21 days ago Darzalex subcutaneous regimen approved by European Commission - 2 months ago
2	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Alzheimer's Data Withdrawn - about 1 month ago BTK Inhibitor Reduces Brain Lesions in Relapsing MS - about 1 year ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 9 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 10 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - about 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - about 1 year ago STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment - about 1 year ago STAT+: Pharmalittle: Eisai reports injectable version of Alzheimer’s drug as effective as IV; Pfizer says combo flu and Covid shot shows strong response - about 1 year ago STAT+: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - about 1 year ago
4	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	European Parliament calls for proposals to reform MDR and IVDR by end of Q1 - 2 months ago EMA updates advice on drug-device combinations under MDR, IVDR - 7 months ago FDA hits Renovo with warning letter over reprocessed medical devices - 9 months ago
5	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug - 3 months ago STAT+: Pharmalittle: End of biotech’s stock market malaise may be near; cancer drug shortages hit rural clinics hard - over 1 year ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 3 months ago FDA Grants Orphan Drug, Fast Track Designation to RLS-0071 for aGVHD - 4 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - about 1 year ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Pharmalittle: We’re reading about a negative U.K. review of Leqembi, Bavarian Nordic’s strong earnings, and more - 4 months ago STAT+: Madrigal wins first U.S. approval for drug to treat liver disease MASH - 10 months ago STAT+: First medicine developed to treat MASH expected to be approved soon - 10 months ago
8	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: U.K.’s cost-effectiveness agency gives negative review of Alzheimer’s drug Leqembi - 4 months ago STAT+: European regulators consider appeal over Amylyx ALS drug - about 1 year ago
9	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GSK5764227 Receives Breakthrough Therapy Designation to Treat Extensive-Stage Small–Cell Lung Cancer - 4 months ago FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 9 months ago FDA Grants Breakthrough Device Designation for Neuroimmune Modulation Platform To Treat MS - 10 months ago Researchers Compare Reimbursement and Access to New Treatments in European Lung Cancer Care - 10 months ago
10	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 4 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 5 months ago To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 9 months ago

Journalists covering REMS